A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

被引:18
作者
Leroy, L. [1 ]
Lafarge, X. [2 ]
Blouin, L. [2 ]
Bijou, F. [3 ]
Durrieu, F. [4 ]
Olivier, E. [5 ]
Le Moulec, S. [1 ]
机构
[1] Bergonie Inst, Dept Med Oncol, Bordeaux, France
[2] EFS, INSERM, Unit 1035, Bordeaux, France
[3] Bergonie Inst, Dept Med Hematol, Bordeaux, France
[4] Bergonie Inst, Dept Biol Hematol, Bordeaux, France
[5] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
关键词
IPILIMUMAB-INDUCED THROMBOCYTOPENIA;
D O I
10.1093/annonc/mdx693
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:514 / 515
页数:3
相关论文
共 4 条
[1]  
Ahmad S, 2012, J Oncol Pharm Pract, V18, P287, DOI 10.1177/1078155211411001
[2]   Treatment possibilities of ipilimumab-induced thrombocytopenia-case study and literature review [J].
Kopecky, Jindrich ;
Trojanova, Petronela ;
Kubecek, Ondrej ;
Kopecky, Otakar .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) :381-384
[3]   Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer [J].
Reck, Martin ;
Rodriguez-Abreu, Delvys ;
Robinson, Andrew G. ;
Hui, Rina ;
Csoszi, Tibor ;
Fulop, Andrea ;
Gottfried, Maya ;
Peled, Nir ;
Tafreshi, Ali ;
Cuffe, Sinead ;
O'Brien, Mary ;
Rao, Suman ;
Hotta, Katsuyuki ;
Leiby, Melanie A. ;
Lubiniecki, Gregory M. ;
Shentu, Yue ;
Rangwala, Reshma ;
Brahmer, Julie R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1823-1833
[4]  
Sajjad MZ, 2013, J CLIN ONCOL, V31